|
^ CELG: Intraday Hourly Forecast Similar Waves GapOpen Research Timing Gains Losses Strategies Practice |
Wed. Nov. 20, 2019 | Trading Signals: CELG Stock Price Prediction and Forecast (Wed. Nov. 20, 2019 - Wed. Nov. 20, 2019)(Celgene Corporation)
| CELG latest price $108.2400 (0%) ($108.2400 - $108.2400) on Wed. Nov. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | 0 | Latest Price | $108.2400(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CELG advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CELG price | CELG will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $21.65(399.95%) | 10 Day Moving Average | $0(INF%) | 20 Day Moving Average | $0(INF%) | To recent high | 0% | To recent low | 0% | Market Cap | $77.002b | | | | Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | $. CELG price fluctuates within NAN% (three month std-dev: 0%) daily (68% of days).
getNextHourMoveProbability failed |
|